Source BioScience, Illumina to Develop Genetic Test for Cancer | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Source BioScience today announced a collaboration with Illumina and Barts Cancer Institute for the development of an integrated genetic test for characterizing cancer tumors at the molecular level.

The goal is to develop the test to improve cancer diagnosis and treatment outcomes for patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.